CA
PFE icon

CapWealth Advisors’s Pfizer PFE Stock Holding History

CapWealth Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-264,160
Closed -$15.6M – 128
2021
Q4 		$15.6M Buy
264,160
+24,843
+10% +$1.23M 1.59% 25
2021
Q3 		$10.3M Buy
+239,317
New +$10.6M 1.13% 38
2016
Q4 		– Sell
-1,038
Closed -$33K – 214
2016
Q3 		$33K Buy
1,038
+32
+3% +$1.07K 0.01% 156
2016
Q2 		$34K Sell
1,006
-377
-27% -$12K 0.01% 158
2016
Q1 		$39K Buy
1,383
+377
+37% +$10.8K 0.01% 149
2015
Q4 		$31K Hold
1,006
– – 0.01% 138
2015
Q3 		$30K Sell
1,006
-1,581
-61% -$50.7K 0.01% 137
2015
Q2 		$82K Buy
2,587
+215
+9% +$7.01K 0.02% 111
2015
Q1 		$78K Buy
+2,372
New +$75.4K 0.02% 118
2014
Q4 		– Sell
-4,918
Closed -$138K – 221
2014
Q3 		$138K Buy
4,918
+324
+7% +$9.09K 0.03% 95
2014
Q2 		$129K Buy
4,594
+2
+0% +$57 0.03% 97
2014
Q1 		$140K Buy
4,592
+2
+0% +$60 0.04% 89
2013
Q4 		$133K Sell
4,590
-1,421
-24% -$41.4K 0.03% 101
2013
Q3 		$164K Buy
6,011
+1,319
+28% +$35.9K 0.05% 92
2013
Q2 		$125K Buy
+4,692
New +$130K 0.04% 104

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

CapWealth Advisors's PFE Position: Q1 2022 in Review

CapWealth Advisors sold out of Pfizer (PFE) in Q1 2022, closing a stake of 264,160 shares — an estimated $15.6M sold.

CapWealth Advisors first reported a position in PFE in Q2 2013 and held it in 15 quarters. The position peaked at $15.6M in Q4 2021. 3,195 funds tracked by Wall St. Rank hold PFE as of Q1 2022.

  • CapWealth Advisors reported no remaining Pfizer position as of Q1 2022 after selling out during the quarter.
  • CapWealth Advisors sold 264,160 Pfizer shares in Q1 2022, an estimated $15.6M.
  • CapWealth Advisors first reported a position in Pfizer in Q2 2013 and held it in 15 quarters.
  • CapWealth Advisors's Pfizer position peaked at $15.6M in Q4 2021.
  • 3,195 funds tracked by Wall St. Rank held Pfizer as of Q1 2022.

Based on CapWealth Advisors's 13F filing for Q1 2022, filed 2 May 2022.